Advertisement
Review article| Volume 23, ISSUE 4, P903-913, December 2003

Download started.

Ok

Molecular detection of infections associated with neoplasia

  • Travis Henry
    Affiliations
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Wittson Hall, Room 4039, 986495 Nebraska Medical Center, Omaha, NE 68198-6495, USA
    Search for articles by this author
  • Stefano Tarantolo
    Correspondence
    Corresponding author. Department of Internal Medicine, 987680 Nebraska Medical Center, Omaha, NE 68198-7680.
    Affiliations
    Department of Internal Medicine, Division of Hematology and Oncology, University of Nebraska Medical Center, Lied Transplant Center, Room 8717, 987680 Nebraska Medical Center, Omaha, NE 68198-7680, USA
    Search for articles by this author
      Cancer is the third leading cause of death in the United States and ranks among the top five causes of death worldwide. Scientists have searched for an infectious etiology of malignancies with little success. Although epidemiologic studies have suggested links between various biologic agents and certain malignancies, it has been the recent advances in molecular biology techniques that have led to the discovery of several examples of viral, bacterial, and even parasitic organisms as carcinogenic agents. The etiology of neoplastic diseases such as adult T-cell leukemia, hepatocellular carcinoma, and mucosa-associated lymphoid tissue (MALT) lymphoma has been attributed directly to human T-cell leukemia virus, hepatitis B and C, and Helicobacter pylori respectively.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Orlow I.
        • Roy P.
        • Barz A.
        • Canchola R.
        • Song Y.
        • Berwick M.
        Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations.
        J Mol Diagn. 2001; 3: 158-163
        • Marsh D.J.
        • Theodosopoulos G.
        • Howell V.
        • Richardson A.L.
        • Benn D.E.
        • Proos A.L.
        • et al.
        Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography.
        Neoplasia. 2001; 3: 236-244
        • Chan W.C.
        • Huang J.Z.
        Gene expression analysis in aggressive NHL.
        Ann Hematol. 2001; 80: B38-B41
        • Alizadeh A.A.
        • Eisen M.B.
        • Davis R.E.
        • Ma C.
        • Lossos I.S.
        • Rosenwald A.
        • et al.
        Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
        Nature. 2000; 403: 503-511
        • Kanegane H.
        • Yachie A.
        • Miyawaki T.
        • Tosato G.
        EBV-NK cells interactions and lymphoproliferative disorders.
        Leuk Lymphoma. 1998; 29: 491-498
        • Lemon S.M.
        • Hutt L.M.
        • Shaw J.E.
        • Li J.L.
        • Pagano J.S.
        Replication of EBV in epithelial cells during infectious mononucleosis.
        Nature. 1977; 268: 268-270
        • Tong X.
        • Wang F.
        • Thut C.J.
        • Kieff E.
        The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein.
        J Virol. 1995; 69: 585-588
        • Henderson S.
        • Rowe M.
        • Gregory C.
        • Croom-Carter D.
        • Wang F.
        • Longnecker R.
        • et al.
        Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.
        Cell. 1991; 65: 1107-1115
        • Fennewald S.
        • van Santen V.
        • Kieff E.
        Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.
        J Virol. 1984; 51: 411-419
        • Cheung A.
        • Kieff E.
        Long internal direct repeat in Epstein-Barr virus DNA.
        J Virol. 1982; 44: 286-294
        • Wagner H.J.
        • Bein G.
        • Bitsch A.
        • Kirchner H.
        Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction.
        J Clin Microbiol. 1992; 30: 2826-2829
        • Lo Y.M.
        • Chan L.Y.
        • Lo K.W.
        • Leung S.F.
        • Zhang J.
        • Chan A.T.
        • et al.
        Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.
        Cancer Res. 1999; 59: 1188-1191
        • Lei K.I.
        • Chan L.Y.
        • Chan W.Y.
        • Johnson P.J.
        • Lo Y.M.
        Circulating cell-free Epstein-Barr virus DNA levels in patients with EBV-associated lymphoid malignancies.
        Ann N Y Acad Sci. 2001; 945: 80-83
        • Islam T.C.
        • Lindvall J.
        • Wennborg A.
        • Branden L.J.
        • Rabbani H.
        • Smith C.I.
        Expression profiling in transformed human B cells: influence of Btk mutations and comparison to B cell lymphomas using filter and oligonucleotide arrays.
        Eur J Immunol. 2002; 32: 982-993
        • Jabs W.J.
        • Hennig H.
        • Kittel M.
        • Pethig K.
        • Smets F.
        • Bucsky P.
        • et al.
        Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders.
        J Clin Microbiol. 2001; 39: 564-569
        • Van Esser J.W.
        • Niesters H.G.
        • Van Der Holt B.
        • Meijer E.
        • Osterhaus A.D.
        • Gratama J.W.
        • et al.
        Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.
        Blood. 2002; 99: 4364-4369
        • Chang Y.
        • Cesarman E.
        • Pessin M.S.
        • Lee F.
        • Culpepper J.
        • Knowles D.M.
        • et al.
        Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
        Science. 1994; 266: 1865-1869
        • Sarid R.
        • Flore O.
        • Bohenzky R.A.
        • Chang Y.
        • Moore P.S.
        Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1).
        J Virol. 1998; 72: 1005-1012
        • Chatterjee M.
        • Osborne J.
        • Bestetti G.
        • Chang Y.
        • Moore P.S.
        Viral IL-6-induced cell proliferation and immune evasion of interferon activity.
        Science. 2002; 298: 1432-1435
        • Kirshner J.R.
        • Staskus K.
        • Haase A.
        • Lagunoff M.
        • Ganem D.
        Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis.
        J Virol. 1999; 73: 6006-6014
        • Godden-Kent D.
        • Talbot S.J.
        • Boshoff C.
        • Chang Y.
        • Moore P.
        • Weiss R.A.
        • et al.
        The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1.
        J Virol. 1997; 71: 4193-4198
        • Platt G.M.
        • Cannell E.
        • Cuomo M.E.
        • Singh S.
        • Mittnacht S.
        Detection of the human herpesvirus 8-encoded cyclin protein in primary effusion lymphoma-derived cell lines.
        Virology. 2000; 272: 257-266
        • Pan L.
        • Milligan L.
        • Michaeli J.
        • Cesarman E.
        • Knowles D.M.
        Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma.
        J Mol Diagn. 2001; 3: 32-38
        • Stamey F.R.
        • Patel M.M.
        • Holloway B.P.
        • Pellett P.E.
        Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens.
        J Clin Microbiol. 2001; 39: 3537-3540
        • Spira T.J.
        • Lam L.
        • Dollard S.C.
        • Meng Y.X.
        • Pau C.P.
        • Black J.B.
        • et al.
        Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection.
        J Clin Microbiol. 2000; 38: 2174-2180
        • Lallemand F.
        • Desire N.
        • Rozenbaum W.
        • Nicolas J.C.
        • Marechal V.
        Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay.
        J Clin Microbiol. 2000; 38: 1404-1408
        • Gessi M.
        • Cattani P.
        • Maggiano N.
        • Scambia G.
        • Lauriola L.
        • Ranelletti F.O.
        • et al.
        Demonstration of human herpesvirus 8 in a case of primary vaginal epithelioid angiosarcoma by in situ hybridization, electron microscopy, and polymerase chain reaction.
        Diagn Mol Pathol. 2002; 11: 146-151
        • Alkan S.
        • Eltoum I.A.
        • Tabbara S.
        • Day E.
        • Karcher D.S.
        Usefulness of molecular detection of human herpesvirus-8 in the diagnosis of Kaposi sarcoma by fine-needle aspiration.
        Am J Clin Pathol. 1999; 111: 91-96
        • Nuovo M.
        • Nuovo G.
        Utility of HHV8 RNA detection for differentiating Kaposi's sarcoma from its mimics.
        J Cutan Pathol. 2001; 28: 248-255
        • Kulke R.
        • DiMaio D.
        Biological properties of the deer papillomavirus E5 gene in mouse C127 cells: growth transformation, induction of DNA synthesis, and activation of the platelet-derived growth factor receptor.
        J Virol. 1991; 65: 4943-4949
        • Conrad M.
        • Goldstein D.
        • Andresson T.
        • Schlegel R.
        The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors.
        Virology. 1994; 200: 796-800
        • Neary K.
        • DiMaio D.
        Open reading frames E6 and E7 of bovine papillomavirus type 1 are both required for full transformation of mouse C127 cells.
        J Virol. 1989; 63: 259-266
        • Scheffner M.
        • Werness B.A.
        • Huibregtse J.M.
        • Levine A.J.
        • Howley P.M.
        The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
        Cell. 1990; 63: 1129-1136
        • Ha P.K.
        • Pai S.I.
        • Westra W.H.
        • Gillison M.L.
        • Tong B.C.
        • Sidransky D.
        • et al.
        Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity.
        Clin Cancer Res. 2002; 8: 1203-1209
        • Pornthanakasem W.
        • Shotelersuk K.
        • Termrungruanglert W.
        • Voravud N.
        • Niruthisard S.
        • Mutirangura A.
        Human papillomavirus DNA in plasma of patients with cervical cancer.
        BMC Cancer. 2001; 1: 2
        • Scheungraber C.
        • Muller B.
        • Kohler C.
        • Possover M.
        • Leistritz S.
        • Schneider A.
        • et al.
        Detection of disseminated tumor cells in patients with cervical cancer.
        J Cancer Res Clin Oncol. 2002; 128: 329-335
        • Harima Y.
        • Sawada S.
        • Nagata K.
        • Sougawa M.
        • Ohnishi T.
        Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy.
        Int J Radiat Oncol Biol Phys. 2002; 52: 1345-1351
        • Crovella S.
        • Pirulli D.
        • De Santo D.
        • De Seta F.
        • Boniotto M.
        • Braida L.
        • et al.
        Quantitative in situ detection of high-risk human papillomavirus in cytological specimens by SYBR Green I fluorescent labeling.
        Clin Exp Med. 2002; 2: 1-6
        • Lorincz A.T.
        • Castle P.E.
        • Sherman M.E.
        • Scott D.R.
        • Glass A.G.
        • Wacholder S.
        • et al.
        Viral load of human papillomavirus and risk of CIN3 or cervical cancer.
        Lancet. 2002; 360: 228-229
        • Koutsky L.A.
        • Ault K.A.
        • Wheeler C.M.
        • Brown D.R.
        • Barr E.
        • Alvarez F.B.
        • et al.
        A controlled trial of a human papillomavirus type 16 vaccine.
        N Engl J Med. 2002; 347: 1645-1651